
Abbott India Ltd. is Rated Hold by MarketsMOJO
2026-11-13 10:12:22Abbott India Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 8 November 2026. While the rating was revised on that date, the analysis below reflects the stock’s current fundamentals, returns, and financial metrics as of 13 November 2026, providing investors with an up-to-date view of the company’s position in the market.
Read MoreAbbott India Gains 2.92%: 4 Key Factors Shaping This Week’s Momentum
2026-11-07 15:00:36Key Events This Week 2 Nov: Stock opens week at Rs.25,783.50 with 0.74% gain 4 Nov: Intraday high of Rs.26,833.75 on 5.4% surge 5 Nov: Mixed technical signals emerge amid 5.20% price rally 6 Nov: Q2 FY27 results confirm continued growth momentum Week OpenRs.25,783.50 Week CloseRs.26,340.05</div...
Read More
Abbott India Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals
2026-11-05 08:05:00Abbott India Ltd. has experienced a notable shift in its technical momentum, moving from a bearish to a mildly bearish trend as of late September 2026. Despite a strong intraday rally pushing the stock price to ₹27,420, technical indicators present a complex picture, with bearish signals dominating monthly charts while weekly and daily measures show mixed or mildly bullish tendencies. This nuanced technical landscape warrants a detailed analysis for investors navigating the Pharmaceuticals & Biotechnology sector.
Read More
Abbott India Ltd: Valuation Shifts Signal Heightened Price Premium in Pharmaceuticals Sector
2026-11-05 08:02:31Abbott India Ltd has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating, driven by elevated price-to-earnings and price-to-book ratios. Despite robust return metrics and solid market performance over the long term, the stock’s current premium valuation raises questions about its price attractiveness relative to peers and historical averages.
Read More
Abbott India Ltd. Surges 5.4% to Day's High of Rs 26,833.75 — Outperforms Sector by 3.8 Percentage Points
2026-11-04 15:18:28The Sensex rose 0.39% on 4 Nov 2026, yet Abbott India Ltd. outpaced the broader market with a 5.4% gain, outperforming its Pharmaceuticals & Biotechnology sector by 3.8 percentage points. This strong single-session performance rewrites the short-term narrative for the mid-cap stock, which has been on a steady upward trajectory over the past three days.
Read More
Abbott India Ltd. is Rated Sell by MarketsMOJO
2026-11-01 10:10:33Abbott India Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Abbott India Ltd: Valuation Shifts Signal Heightened Price Risk Amid Strong Fundamentals
2026-10-29 08:01:17Abbott India Ltd has recently undergone a significant shift in its valuation parameters, moving from an expensive to a very expensive rating. Despite robust operational metrics and a solid return profile, the stock’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios raise questions about its price attractiveness relative to historical levels and peer benchmarks.
Read More
Abbott India Ltd. is Rated Sell
2026-10-21 10:10:38Abbott India Ltd. is rated Sell by MarketsMOJO, with this rating last updated on 28 September 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 October 2026, providing investors with the latest insights into its performance and outlook.
Read MoreAbbott India Ltd Declines 1.18%: Bearish Momentum and Valuation Concerns Shape the Week
2026-10-10 14:03:03Key Events This Week Oct 5: Technical momentum shifts to bearish amid market volatility Oct 6: Valuation grade downgraded from 'very expensive' to 'expensive' Oct 9: Stock rebounds with a 1.44% gain on positive market sentiment Week Summary: Stock closes at Rs.25,999.85, down 1.18% vs Sensex -0.57% Week OpenRs.26,310.45 Wee...
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
06-Nov-2026 | Source : BSENewspaper Advertisement of the Unaudited Financial Results of the Company for the quarter and half year ended on September 30 2026.
Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2026.
05-Nov-2026 | Source : BSEUnaudited Financial Results of the Company for the quarter and half year ended September 30 2026.
Board Meeting Outcome for Outcome Of Board Meeting
05-Nov-2026 | Source : BSEUnaudited Financial Results of the Company for the quarter and half year ended September 30 2026.
Corporate Actions
No Upcoming Board Meetings
Abbott India Ltd. has declared 5250% dividend, ex-date: 24 Jul 26
No Splits history available
No Bonus history available
No Rights history available